Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?

To describe the burden of pneumococcal disease and associated risk factors in the Canadian adult population, delineate available pneumococcal vaccines and associated efficacy and effectiveness data, and review current pneumococcal vaccine recommendations and community-acquired pneumonia (CAP) preven...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Canadian family physician 2019-09, Vol.65 (9), p.625-633
Hauptverfasser:	Kaplan, Alan, Arsenault, Pierre, Aw, Brian, Brown, Vivien, Fox, George, Grossman, Ron, Jadavji, Taj, Laferrière, Craig, Levitz, Suzanne, Loeb, Mark, McIvor, Andrew, Mody, Christopher H, Poulin, Yannick, Shapiro, Marla, Tessier, Dominique, Théorêt, Francois, Weiss, Karl, Yaremko, John, Zhanel, George
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Advisory Committees Canada Community-Acquired Infections - immunology Community-Acquired Infections - microbiology Community-Acquired Infections - prevention & control Disease prevention Humans Immunization Immunization Schedule Pneumococcal Vaccines - administration & dosage Pneumococcal Vaccines - immunology Pneumonia Pneumonia, Pneumococcal - immunology Pneumonia, Pneumococcal - prevention & control Practice Practice Guidelines as Topic Risk factors Streptococcus pneumoniae Vaccines Vaccines, Conjugate - administration & dosage Vaccines, Conjugate - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!